Assessment of EGFR Mutation Status in Lung Adenocarcinoma by Immunohistochemistry Using Antibodies Specific to the Two Major Forms of Mutant EGFR

This publication has 17 references indexed in Scilit:

• An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors
  Oncogene, 2009
• Mutation-Specific Antibodies for the Detection of EGFR Mutations in Non–Small-Cell Lung Cancer
  Clinical Cancer Research, 2009
• EGFR Mutations in Lung Adenocarcinomas
  The Journal of Molecular Diagnostics, 2008
• Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond
  Laboratory Investigation, 2008
• Epidermal Growth Factor Receptor (EGFR) High Gene Copy Number and Activating Mutations in Lung Adenocarcinomas Are Not Consistently Accompanied by Positivity for EGFR Protein by Standard Immunohistochemistry
  The Journal of Molecular Diagnostics, 2008
• Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal Method
  Clinical Cancer Research, 2007
• Epidermal growth factor receptor mutations in lung cancer
  Nature Reviews Cancer, 2007
• Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lung
  Cancer, 2006
• Detection ofEGFRGene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay
  Clinical Cancer Research, 2006
• Rapid Polymerase Chain Reaction-Based Detection of Epidermal Growth Factor Receptor Gene Mutations in Lung Adenocarcinomas
  The Journal of Molecular Diagnostics, 2005